Piper Jaffray Cuts Price Target on Sequenom (SQNM) as Guidance is Below Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Sequenom Announces Contract with Anthem BlueCross
March 2, 2016 4:39 PM ESTSAN DIEGO, March 2, 2016 /PRNewswire/ -- Sequenom, Inc., (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced the completion of an agreement with Anthem BlueCross. The agreement provides in-network coverage for Anthem's California customers for Sequenom Laboratories' noninvasive prenatal tests in both high and average risk pregnancies, beginning March 1, 2016.Â
"We are excited to be contracted with Anthem BlueCross," said Dr. Dirk van den Boom,... More
Sequenom, Inc. Reports 2015 Financial Results
March 2, 2016 4:05 PM ESTSAN DIEGO, March 2, 2016 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today reported results for the fourth quarter and full year 2015.
Fourth Quarter and Full Year 2015 Highlights:
Fourth quarter total accessions of 42,200, up from 41,000 in Q3 2015 Fourth quarter noninvasive prenatal test (NIPT) accessions of 37,300, up from 35,500 in Q3 2015 Total accessions of 180,400... More